Cape Investment Advisory’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.4K	Buy	+35	New	+$4.4K	﹤0.01%	791
2024 Q1	–	Sell	-20	Closed	-$2.64K	–	1088
2023 Q4	$2.64K	Buy	+20	New	+$2.64K	﹤0.01%	893